Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (4R)-1,3,4,5-tetrahydro-4-methyl-6-[1-methyl-3-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-5-yl]-2H-1,5-be | 1884712-47-3 | MFCD30489741 | 99.9% | 386.45 | C22H22N6O | 50 MG
SDP

Supplier:  Medchemexpress LLC HY10048250MG

Encompass_Preferred

CPI-637 is a selective, cell-active benzodiazepinone inhibitor of the CBP and EP300 bromodomains used as a research reagent for epigenetic and cancer-biology studies. It shows nanomolar biochemical potency and cellular target engagement and is supplied as a high-purity solid for laboratory use.

  • Selective CBP/EP300 bromodomain inhibition (CBP IC50 ≈ 0.03 μM; EP300 IC50 ≈ 0.051 μM).
  • Low activity against BRD4 BD-1 (IC50 ≈ 11.0 μM), indicating >700-fold selectivity.
  • Cellular activity with CBP BRET EC50 ≈ 0.3 μM.
  • High purity solid suitable for biochemical and cellular assays.
  • Stable under recommended storage conditions (powder: -20°C; in solvent: -80°C).
  • Available in small research package sizes (for example, 50 mg).

Catalog No. 50-002-13781


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.